Zai Lab Limited

SHSC:9688 Stock Report

Market Cap: HK$22.5b

Zai Lab Management

Management criteria checks 3/4

Zai Lab's CEO is Samantha Du, appointed in Jan 2014, has a tenure of 10.92 years. total yearly compensation is $12.04M, comprised of 7.2% salary and 92.8% bonuses, including company stock and options. directly owns 0.46% of the company’s shares, worth HK$102.66M. The average tenure of the management team and the board of directors is 2.2 years and 6.3 years respectively.

Key information

Samantha Du

Chief executive officer

US$12.0m

Total compensation

CEO salary percentage7.2%
CEO tenure10.9yrs
CEO ownership0.5%
Management average tenure2.2yrs
Board average tenure6.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Samantha Du's remuneration changed compared to Zai Lab's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$271m

Jun 30 2024n/an/a

-US$298m

Mar 31 2024n/an/a

-US$339m

Dec 31 2023US$12mUS$869k

-US$335m

Sep 30 2023n/an/a

-US$301m

Jun 30 2023n/an/a

-US$393m

Mar 31 2023n/an/a

-US$410m

Dec 31 2022US$20mUS$830k

-US$443m

Sep 30 2022n/an/a

-US$593m

Jun 30 2022n/an/a

-US$529m

Mar 31 2022n/an/a

-US$554m

Dec 31 2021US$15mUS$774k

-US$704m

Sep 30 2021n/an/a

-US$569m

Jun 30 2021n/an/a

-US$537m

Mar 31 2021n/an/a

-US$454m

Dec 31 2020US$9mUS$689k

-US$269m

Sep 30 2020n/an/a

-US$239m

Jun 30 2020n/an/a

-US$240m

Mar 31 2020n/an/a

-US$201m

Dec 31 2019US$9mUS$656k

-US$195m

Sep 30 2019n/an/a

-US$212m

Jun 30 2019n/an/a

-US$181m

Mar 31 2019n/an/a

-US$160m

Dec 31 2018US$6mUS$638k

-US$139m

Compensation vs Market: Samantha's total compensation ($USD12.04M) is above average for companies of similar size in the Hong Kong market ($USD471.21K).

Compensation vs Earnings: Samantha's compensation has been consistent with company performance over the past year.

CEO

Samantha Du (58 yo)

10.9yrs

Tenure

US$12,042,285

Compensation

Dr. Ying Du, Ph D., also known as Samantha, serves as Founding Managing Director at Quan Capital. She served as Venture Partner at Sequoia Capital China.Dr. Du serves as an adjunct professor at Fudan Univ...

Leadership Team

NamePositionTenureCompensationOwnership
Ying Du
Founder10.9yrsUS$12.04m0.46%
HK$ 102.7m
Joshua L. Smiley
President & COO2.3yrsUS$5.55m0.040%
HK$ 9.0m
Rafael G. Amado
President and Head of Global Research & Development1.9yrsUS$4.87m0.019%
HK$ 4.2m
Yajing Chen
Chief Financial Officer1.4yrsUS$2.01m0.014%
HK$ 3.2m
Peter Huang
Chief Scientific Officer2.1yrsno datano data
Christine Chiou
Senior VP & Head of Investor Relations1.6yrsno datano data
Frazor Titus Edmondson
Chief Legal Officer & Joint Corporate Secretary4.3yrsUS$5.63m0.027%
HK$ 6.0m
Ning Xu
Executive VP & Head of Clinical Operations10.9yrsno datano data
Jonathan J. Wang
Chief Business Officer10.9yrsno datano data
James Yan
Chief Operating Officer of R&D9.9yrsno datano data
Tong Zhu
Chief Commercial Officer of Greater Chinaless than a yearno datano data
Robert Brown
Chief Medical Officer of Oncology1.3yrsno datano data

2.2yrs

Average Tenure

58yo

Average Age

Experienced Management: 9688's management team is considered experienced (2.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Ying Du
Founder10.9yrsUS$12.04m0.46%
HK$ 102.7m
Leon Moulder
Independent Director4.9yrsUS$574.35k0.037%
HK$ 8.4m
Peter Karl Wirth
Independent Director7.9yrsUS$576.15k0.33%
HK$ 75.1m
John David Diekman
Lead Independent Director7.9yrsUS$608.44k0.063%
HK$ 14.1m
Scott William Morrison
Independent Director3.2yrsUS$570.77k0.049%
HK$ 10.9m
William David Lis
Independent Director6.2yrsUS$567.03k0.049%
HK$ 11.0m
Michel Vounatsos
Independent Director1.9yrsUS$821.25k0.017%
HK$ 3.8m
Richard Brian Gaynor
Independent Director3.1yrsUS$564.98k0.023%
HK$ 5.3m
Kai-Xian Chen
Independent Director6.3yrsUS$557.48k0.044%
HK$ 9.8m
Wing-Yu Leung
Independent Director10.9yrsno datano data

6.3yrs

Average Tenure

66.5yo

Average Age

Experienced Board: 9688's board of directors are considered experienced (6.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 08:41
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Zai Lab Limited is covered by 28 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael MengBOCI Research Ltd.
Linda LuBOCI Research Ltd.
Wai Chak YuenBOCI Research Ltd.